Strength
1 mg/mL
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205009978
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
SIROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA216728On Market Since
1/19/2023
Pharmacological Classes
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors
Related Drugs
Same classification
IMATINIB MESYLATE 100 MG TAB
Generic
72485020290•Armas Pharmaceuticals Inc.
$0.4912
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
00093762998•Teva Pharmaceuticals USA Inc.
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
00378224577•Mylan Pharmaceuticals Inc.
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
00832053209•Upsher-Smith Laboratories LLC
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
00904690104•Major Pharmaceuticals
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
31722029690•Camber Pharmaceuticals Inc.
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
42292004303•Mylan Institutional LLC
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
43598034431•Dr. Reddy's Laboratories Inc.
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
47335047281•Sun Pharmaceutical Industries Inc.
$0.7940
per EA
IMATINIB MESYLATE 100 MG TAB
Generic
59651024090•Aurobindo Pharma Limited
$0.7940
per EA